Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada,
or Mexico who read any 3 of the selected continuing medical education (CME)
articles in this issue of Archives of Dermatology,
complete the CME Evaluation Form, and fax it to the number or mail it to the
address at the bottom of the CME Evaluation Form are eligible for Category
1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation
Council for Continuing Medical Education to sponsor continuing medical education
for physicians. The AMA designates this educational activity for up to 1 hour
of Category 1 credit per Archives of Dermatology
issue toward the AMA Physician's Recognition Award (PRA). Each physician should
claim only those hours of credit that were actually spent in the educational
activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico,
or Canada are eligible for CME credit even if they live or practice in other
countries. Physicians licensed in other countries are also welcome to participate
in this CME activity. However, the PRA is only available to physicians licensed
in the United States, Canada, or Mexico.
Earning Credit
To earn credit, read the articles designated for CME credit carefully
and complete the CME Evaluation Form. The CME Evaluation Form must be submitted
within 3 months of the issue date. A certificate awarding 1 hour of Category
1 CME credit will be faxed or mailed to you; it is then your responsibility
to maintain a record of credit received. Questions about CME processing should
be directed to The Blackstone Group; tel: (312) 419-0400, ext 225; fax: (312)
269-1636.
CME Evaluation Form
One of our goals is to assess continually the educational needs of our
readers so we may enhance the educational effectiveness of the Archives of Dermatology. To achieve this goal, we need your help. You
must complete the CME Evaluation Form to receive credit.
Statement of Educational Purpose
For a complete description of the ARCHIVES' mission statement, please
refer to the table of contents.
A flexible curriculum of article topics is developed annually by the
journal's editorial board and is then supplemented throughout the year with
information gained from readers, authors, reviewers, and editors. The Reader's
Choice CME activity allows readers, as adult learners, to determine their
own educational needs and to assist the editors in addressing their needs
in future issues.
Readers of the Archives of Dermatology should
be able to attain the following educational objectives: (1) select and read
at least 3 articles per issue to gain new medical information on topics of
particular interest to them as physicians, (2) assess its value to them as
practicing physicians, and (3) think carefully about how this new information
may influence their own practices.
CME Articles in This Issue of Archives of Dermatology
The following articles in this issue may be read for CME credit:
Psoriasis as a Model for T-Cell–Mediated Disease:
Immunobiologic and Clinical Effects of Treatment With Multiple Doses of Efalizumab,
an Anti–CD11a Antibody (SEE ARTICLE)
Educational Objective: To learn that blocking
CD11 improves the conditions of patients with moderate to severe disease.
Histological Characteristics of Metastasizing Thin
Melanomas: A Case-Control Study of 43 Cases (SEE ARTICLE)
Educational Objective: To learn that significant
regression is a risk factor and that in situ lesions can metastasize.
Nodular Type and Older Age as the Most Significant
Associations of Thick Melanoma in Victoria, Australia (SEE ARTICLE)
Educational Objective: To learn that most thick
lesions are seen in older patients and are the nodular subtype.
Pathology Review of Cases Presenting to a Multidisciplinary
Pigmented Lesion Clinic (SEE ARTICLE)
Educational Objective: To learn that pathology
review in this setting significantly changed the diagnosis in about 10% of
cases.
Reliability of the Histopathologic Diagnosis of Malignant
Melanoma in Childhood (SEE ARTICLE)
Educational Objective: To learn that even among
experts concordance was poor.
The Effectiveness of Tumor Necrosis Factor 
Antibody (Infliximab) in Treating Recalcitrant Psoriasis: A Report of 2 Cases (SEE ARTICLE)
Educational Objective: To learn about a promising
new therapy for severe disease.
